High Distribution Costs Increase Drug Prices In China
This article was originally published in PharmAsia News
Executive Summary
China’s high drug prices could be attributed to its high pharma distribution costs, which constituted 11.1% of overall costs in 2010 and was exacerbated by price wars following the government’s implementation of the Anhui model at the end of 2010.